AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

BACKGROUND & AIMS: Two recently developed composite models, the alpha-fetoprotein (AFP) score and Metroticket 2.0, could be used to select patients with hepatocellular carcinoma (HCC) who are candidates for liver transplantation (LT). The aim of this study was to compare the predictive performan...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñero, Federico, Costentin, Charlotte, Degroote, Helena, Notarpaolo, Andrea, Boin, Ilka FSF., Boudjema, Karim, Baccaro, Cinzia, Chagas, Aline, Bachellier, Philippe, Ettorre, Giuseppe Maria, Poniachik, Jaime, Muscari, Fabrice, Dibenedetto, Fabrizio, Duque, Sergio Hoyos, Salame, Ephrem, Cillo, Umberto, Marciano, Sebastián, Vanlemmens, Claire, Fagiuoli, Stefano, Carrilho, Flair, Cherqui, Daniel, Burra, Patrizia, Van Vlierberghe, Hans, Lai, Quirino, Silva, Marcelo, Rubinstein, Fernando, Duvoux, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860475/
https://www.ncbi.nlm.nih.gov/pubmed/36691474
http://dx.doi.org/10.1016/j.jhepr.2022.100644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860475/
https://www.ncbi.nlm.nih.gov/pubmed/36691474
http://dx.doi.org/10.1016/j.jhepr.2022.100644

Ejemplares similares